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Abstract
Whole genome sequencing of 616 asymptomatically carried pneumococci was used to study the
impact of the 7-valent pneumococcal conjugate vaccine. Comparison of closely related isolates
revealed the role of transformation in facilitating capsule switching to non-vaccine serotypes and
the emergence of drug resistance. However, such recombination was found to occur at
significantly different rates across the species, and the evolution of the population was primarily
driven by changes in the frequency of distinct genotypes extant pre-vaccine. These alterations
resulted in little overall effect on accessory genome composition at the population level,
contrasting with the fall in pneumococcal disease rates after the vaccine’s introduction.
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tStreptococcus pneumoniae is a human nasopharyngeal commensal and respiratory pathogen
that represents a major cause of pneumonia, bacteraemia and meningitis. The bacterium’s
best-characterised virulence factor is its polysaccharide capsule, of which there are more
than ninety serologically distinct variants (serotypes) that are associated with markedly
different characteristics1. These may be categorized into serogroups, defined as sets of
serotypes that cross-react with common antisera: for instance, serogroup 23 comprises
serotypes 23F, 23A and 23B. Such serology forms the basis of much pneumococcal
epidemiology, and the capsule is also the target of all licensed vaccine formulations.
In 2000, the polysaccharide-protein conjugate vaccine (PCV7) was introduced for routine
immunization of children in the USA. This contained antigens designed to protect against
seven pneumococcal serotypes (vaccine types, VTs): 4, 6B, 9V, 14, 18C, 19F and 23F. It
was anticipated that this would also provide some cross protection against the vaccine
related serotypes (VRTs) within the same serogroups as these seven targets. Since PCV7’s
introduction, invasive pneumococcal disease (IPD) caused by VTs has declined significantly
across the USA2, accompanied by a smaller rise in disease caused by non-VT, including
VRT, pneumococci3–6. Surveillance in Massachusetts has monitored the contemporaneous
changes in the asymptomatically carried population. Surveys of over 600 children in each of
the winters of 2000–2001, 2003–2004 and 2006–2007 found that between 23% and 30% of
children carried pneumococci, with no evidence of a decline in carriage prevalence
following the introduction of PCV77–9. This reflected an increase in the prevalence of non-
VT pneumococci as the VT strains were gradually eliminated. Nevertheless, by 2003 the
rate of IPD in children under five in the state declined by 69% relative to the pre-vaccine
incidence10, with VRT 19A and non-VT 7F emerging as the dominant IPD serotypes post-
PCV711,12. This reduction in disease incidence, while carriage remained nearly unchanged,
suggests that the NVT that dominated carriage post-PCV7 were, on average, less invasive
than those VT that they replaced11,12. Patterns of antibiotic resistance were also observed to
change13,14; for instance, several of the epidemic multidrug-resistant clones identified by the
Pneumococcal Molecular Epidemiology Network15 (PMEN) predominately express VT and
have consequently declined in frequency since in the introduction of the vaccine.
These substantial alterations to the pneumococcal population resulting from the selective
pressure of PCV7 might be expected to impact genetic diversity across the chromosome,
akin to the ‘periodic selection’ expected in a genetically monomorphic bacterium16.
However, the ability of the pneumococcus to recombine by natural transformation suggests
successful lineages that were mainly VT before PCV7 may persist through variants that have
acquired non-VT capsules, a process called serotype or capsule switching17 that has been
observed throughout the history of the pneumococcus18,19. To better understand the
interplay of clonal replacement and adaptation through recombination in the population’s
response to vaccination, whole genome sequencing was performed on carriage isolates
obtained from Massachusetts children between 2000 and 2007.
Results
Population structure of isolates
A total of 616 isolates were used in this analysis: 133 from 2001, 203 from 2004 and 280
from 2007 (Supplementary Table 1). In terms of their serotype distribution, these
populations represent the pneumococcal community at the point at which PCV7 was
introduced, a community with increased diversity following the introduction of the vaccine,
and a return to equilibrium, respectively20. De novo genome assembly produced sequences
ranging in length from 1.98 Mb to 2.19 Mb (Supplementary Figure 1). The 1,231,516
putative protein coding sequences (CDSs) extracted from these assemblies were grouped
into 5,442 clusters of orthologous genes (COGs). The prevalence of these COGs within the
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tpopulation followed a U-shaped distribution (Supplementary Figure 2), similar to that
calculated using a smaller set of pneumococcal genomes generated using older
technologies19.
A total of 1,194 COGs were present in a single copy in all genomes, and therefore defined as
‘core’. These were used to generate a 1.14 Mb codon alignment, containing 106,196
polymorphic sites, upon which phylogenetic and population clustering analyses were based
(Figure 1). This approach identified fifteen sequence clusters (SCs) corresponding to clades
within the tree, ranging in size from 10 to 98 isolates, with a sixteenth group constituting a
polyphyletic cluster of the remaining low frequency genotypes. All of the monophyletic
sequence clusters showed a high level of consistency with previous genotyping (multilocus
sequence typing, MLST; Supplementary Figure 3)14,21. The tree was rooted on the longest
branch, separating a diverse lineage of unencapsulated strains (SC12) from the rest of the
population. The genotypes in this outgroup, previously associated with outbreaks of
conjunctivitis using MLST data22, are clearly distinct from both the other sequence clusters
and S. pseudopneumoniae when placed in the context of other mitis group streptococci
(Supplementary Figure 4). In contrast, other unencapsulated strains in the collection appear
to reflect sporadic loss of capsule (Supplementary Table 2).
Diversification within sequence clusters
To reconstruct the recent evolutionary history of the population, whole genome alignments
were generated for each sequence cluster through mapping sequence reads for each isolate
against a common reference assembly. Horizontally acquired variation was then identified
using previously described methods23 (Supplementary Figure 5–Supplementary Figure 19).
This approach allows the calculation of the net rate at which polymorphisms are
accumulated through import of sequence from other lineages via transformation relative to
the mutation rate (r/m) for each SC. The estimates for this r/m parameter range from 0.06
(SC7, comprising serotype 7F isolates) to 34.06 (SC15, the multidrug-resistant PMEN14
lineage15). When representing the behavior of each sequence cluster by the distribution of
statistics derived from each branch of the relevant phylogeny, the differences between
sequence clusters are found to be significant whether comparing per site r/m (Kruskal-
Wallis test, χ 2 = 45.71, df = 14, p = 3.97×10−5) or the ratio of homologous recombination
events relative to point mutations (χ 2 = 54.6, p = 9.96 × 10−7). Correspondingly, the
distributions of detected transformation event lengths are consistent between sequence
clusters (Supplementary Figure 20).
The range of isolation dates was used to establish a molecular clock. Fitting an evolutionary
model to four sequence clusters that showed evidence of genetic divergence over time
(Supplementary Figure 21) yielded independent estimates of the point mutation rate
(Supplementary Figure 22). The consensus rate of 1.0×10−6–1.5×10−6 mutations per base
per year is similar to that calculated using a global collection of strains23. This indicates
there is little variation in the substitution rate across the species, with isolates accumulating
two or three polymorphisms each year. Given the number of observed transformation events
and point mutations within each SC, this implies a variable net rate of sequence import into
the sequence clusters: around one transformation event every six to nine years for SC2
isolates, compared with every one to two years for SC15 isolates.
Serotype switching and replacement
Transformation plays an important role in facilitating the process of serotype switching
(Figure 2). SC15 provides a simple example of switching leading to vaccine escape,
previously inferred from MLST24, with a single transformation event at the capsule
biosynthesis (cps) locus leading to the emergence of 19A variants (Supplementary Figure
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t19). These are absent in the 2001 sample, but comprise 80% of the SC15 isolates in 2007.
The most recent common ancestor of these 19A strains is predicted to have existed in 1997
(95% credibility interval 1984–2001). As the acquisition of a 19A capsule by SC15 must
have preceded this most recent common ancestor, it seems likely the emergence of SC15-
serotype 19A represents an increase in frequency of a variant already extant pre-PCV7.
The emergence of 19A variants within SC15 represents the smallest genetic distance
between isolates with different capsule types within a monophyletic sequence cluster; all
other cases of ‘switching’ involve more distinct genotypes that, by implication of the
observed molecular clock, share a common ancestor more distantly in the past. Hence there
is no evidence for serotype switching events occurring post-PCV7. Instead, selection from
variation in the pre-vaccine population by PCV7 appears to be more common: a clear
example can be observed within SC9 (Figure 3). Two-thirds of the group expressed the VT
23F capsule in 2001, declining to an undetectable level in 2007. Instead, all representatives
of the sequence cluster were VRT serotypes 23A and 23B, which have lower odds ratios for
causing IPD than 23F in Massachusetts11, thereby likely contributing to the fall in IPD rates.
However, the original serotype of SC9 is reconstructed as being 23A; in the pre-PCV7 era
the 23F variants, generated through three independent transformations, appear to have been
the most successful. PCV7 reverses this trend as the 23A isolates, in parallel with the 23B
strains formed by a further three separate switches within the phylogeny, appear to fill the
niche vacated by the eliminated 23F isolates. Hence the vaccine caused no change in the
prevalence of SC9, nor did it reduce the diversity of the SC. Apparent serotype switching
that actually reflects the emergence of deep-branching sister taxa is also observed in SC1
and SC6 (Figure 1). By contrast, in the multidrug-resistant SC5 (Supplementary Figure 9)
and SC15 (Supplementary Figure 19) genotypes, the emergence of serotype 19A variants
involves a recent bottleneck constraining post-PCV7 diversity, mirroring what was observed
in PMEN123.
Notwithstanding the substantial turnover of lineages within the population, the effect of
vaccination on the frequencies of individual COGs was modest (Figure 4; Supplementary
Figure 23). The composition of the accessory genome is generally stable throughout the
sampling period. The exceptions are four COGs involved in the synthesis of serogroup 6
capsules: one represents the wciN gene characteristic of serotypes 6A and 6B, both affected
by immunity induced by PCV725. The other three are COGs found in serotype 6C, as well as
type 6A and 6B, and therefore do not drop in frequency to the same extent. As the
biosynthetic genes for the VT capsules 14, 19F and 23F all fall into COGs also required for
the production of the non-VT capsules 15B/C, 19A and 23B, respectively (with the
exception of lrp, unique to the capsule locus of serotype 1426, of which only six
representatives were assembled), PCV7 has little impact even on the prevalence of COGs
involved in capsule synthesis. However, an effect can be detected by quantifying the
diversity within each COG: four COGs found in both the serotype 14 and serogroup 15
biosynthetic loci drop in diversity in 2007, as serotype 14 is eliminated (Supplementary
Figure 24). By contrast, three COGs shared between serogroups 15 and 23 increase in
diversity as 23F is replaced by 23A and 23B, and 15A rises in prevalence post-PCV7. Once
more, the impact of the vaccine on most other COGs is small.
Alterations in antibiotic resistance
Another set of COGs persisting at an intermediate frequency are antibiotic resistance
determinants. Levels of susceptibility to many antibiotics remained stable in Massachusetts
after the introduction of PCV77,9, despite VT serotypes being strongly associated with
multidrug resistance in the USA pre-PCV727,28 and a decline in the dispensing of antibiotics
to children in Massachusetts over the sampled period29. For instance, tetracycline resistance
is typically caused by the tetM gene carried on the Tn916 transposon30 in S. pneumoniae
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t(Figure 5A). The persistence of this gene can be partially attributed to its association with
SC15, which changes little in frequency over time. Additionally, the loss of the tetracycline-
resistant PMEN1 and PMEN15 lineages by 2007 is offset by the emergence of SC3, which
also carries this transposon, from 2004 onwards.
Macrolide resistance is similarly stable, although the causative mechanisms shift over time.
The two resistance determinants common in pneumococci are the ermB rRNA methylase
gene and the mel/mef efflux pump. The former is carried either by Tn917 or Omega
resistance cassettes23,31, both of which are only found inserted into Tn916 in this
population. This means the population of ermB-carrying isolates are a subset of those that
are tetracycline resistant (with the exception of isolate R34–3037, in which the tetM gene is
disrupted by a frameshift mutation); this mechanism also causes cross-resistance to
streptogramin and lincosamide antibiotics. By contrast, the macrolide-specific mel/mef
pump is carried by the Mega element that can insert into Tn916, or be acquired elsewhere in
the chromosome through transformation32. As a consequence of the distribution of Tn916,
ermB shows a more stable association with clades, rising in prevalence as it is carried by
SC3 and the serotype 19A isolates of SC15 (Figure 5B; Supplementary Figure 25). The
Mega cassette falls in prevalence owing to its stable association with SC13 and SC14, which
drop in frequency post-PCV, and SC15 (Figure 5C). However, it also appears in other
monophyletic sequence clusters: five acquisitions are detected within SC11 and seven within
SC8. Such a dispersed distribution ensures it will be difficult to eliminate such a resistance
element using partial coverage vaccines targeting the capsule.
The sequences determining beta lactam resistance also alter post-PCV7. In S. pneumoniae,
beta lactam susceptibility is determined by the sequences of three penicillin binding protein
genes: pbp2x and pbp1a, found either side of the cps locus, and pbp2b, at an unlinked
position in the genome33. Based on pre-2008 resistance breakpoints34, post-PCV7 penicillin
non-susceptibility in Massachusetts was found to be stable, while ceftriaxone resistance fell
significantly8,9. MICs to both drugs are correlated across the sample, with a strain’s
ceftriaxone MIC typically lower than that for benzylpenicillin (Supplementary Figure 26).
Hence this apparent differential response to these antibiotics reflects an underlying trend in
which the most nonsusceptible strains are replaced by those displaying a lower level of
resistance, and therefore meet the threshold MIC for penicillin, but not ceftriaxone,
resistance. To understand these changes, COGs corresponding to pbp1a, pbp2x and pbp2b
were extracted from all taxa and the sequences clustered into alleles, some of which appear
to be mosaic (Figure 6).
Across the sampling period, the dominant allele for each pbp gene was the ancestral,
sensitive form, which altered little in frequency. However, changes in the types of resistant
allele were evident, with the forms of both pbp2b and pbp2x associated with highly beta
lactam resistant isolates falling in frequency (Supplementary Figure 25). Allele 3 of pbp2b,
strongly associated with the multidrug-resistant lineages PMEN1, PMEN3 and PMEN1515,
was partially displaced by alleles 2 and 4, rising due to the increase in prevalence of SC11
and a shift towards resistant isolates within SC6, respectively. Allele 2 of pbp2x, again
associated with the PMEN lineages, was replaced by allele 3, largely as a consequence of
the emergence of SC3 alongside the change within SC6. The analogous analysis of the genes
encoding dihydrofolate reductase and dihydropteroate synthase, certain alleles of which can
cause resistance to sulfa drugs, found a decline in the prevalence of resistant alleles
(Supplementary Figure 27), in line with the observed fall in levels of resistance9. This is
largely the consequence of a shift in the composition of SC1 and the replacement of the
PMEN lineages with SC3 and SC11, which are predominantly sensitive to sulfa drugs.
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frequency of different clades of isolates, the emergence of resistant genotypes through
recombinations affecting penicillin-binding protein genes is also observed. This can be
rapid, as demonstrated when transformation events affecting pbp1a, pbp2x and pbp2b occur
on the same branch of the tree (e.g. starred isolates in Figure 3). One example, albeit on a
long branch, is associated with the emergence of ST3280 isolates within SC6
(Supplementary Figure 10), which are also distinguished from their sister taxa through the
acquisition of a Tn916 element carrying a Mega cassette. However, a frameshift mutation
disrupts the mel gene, which appears to be reflected in an intermediate level of resistance to
erythromycin (between 0.25 and 0.5 μ g ml−1; Supplementary Table 1). This phenotype is
also observed in an SC8 isolate with a Mega element in which the mef gene is disrupted by a
frameshift mutation. The persistence of these distinctive genetic traits in the five closely
related ST3280 isolates was of particular interest as they were all isolated from a single
location in 2007, implying there may be evidence of transmission chains within the dataset.
Population substructuring
To test whether this represented a general phenomenon, and transmission within locations
could be detected from the genomic data, the pairwise distances (in point mutations;
Supplementary Figure 5–Supplementary Figure 19) between all of the taxa within
monophyletic sequence clusters were compared with the locations from which the bacteria
were recovered (listed in Supplementary Table 1). More closely related isolates were much
more likely to have been recovered from the same location than expected by chance (Figure
7). The probability that the members of the pair would come from the same location
decreased approximately exponentially with the point mutation distance between them. The
rate constant calculated from these data implied once two isolates were distinguished by
approximately 18 point mutations, it would be equally likely they would be isolated from the
same, or different, communities in the dataset. Given the mutation rate of 2–3 mutations per
year, this represents around four years of divergence between two strains. Such evidence of
transmission chains indicates that the spread of bacteria within communities is significantly
faster than dissemination of bacteria between them, which occurs sufficiently slowly to be
detectable via point mutations.
Population substructuring may also be produced by the immune status of the host, which
changes with age following successive carriage episodes. Previous work found strains
carrying the type 1 (rlr) pneumococcal pilus, hypothesized to be involved in adhesion to the
nasopharyngeal surface35, were most prevalent in children under five years of age36. This
was attributed to the development of an adaptive immune response to this surface structure,
which precludes bacteria with this antigen from colonizing older children while still
providing a functional benefit in naïve hosts. The resulting niche differentiation will result in
strains adapted to transmission between hosts of different ages. In order to identify antigens
generating a similar signal, a logistic regression against host age (excluding those aged
under 6 months that may be influenced by maternal immunity) was performed for COGs
present at a range of intermediate frequencies. Aside from three rare short COGs, the
function of which is difficult to interpret, the rlr pilus was found to have one of the strongest
relationships with host age, confirming this previous finding (Figure 8). Showing an
association of a similar magnitude is the pclAR gene cluster37, encoding a large protein
antigen present in about half of the sampled bacterial population, and two linked alleles of
the immunoglobulin A protease zmpA and paralogous zinc metalloprotease zmpD, both of
which are large surface-displayed proteins; by contrast, two alternative alleles of zmpAD
show an association with older children. As these antigen COGs are stably associated with
particular genotypes, sequence clusters show varying patterns of association with different
host ages (Supplementary Figure 28). The effect of antigens frequently affected by
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trecombinations, such as pspA and pspC (Supplementary Figure 5–Supplementary Figure
19), is unclear, as these genes are difficult to assemble and fall into multiple COGs owing to
their extensive sequence diversity. The apparently weaker age-association of the mel/mef
efflux pump is, in fact, most pronounced in infants younger than six months, in agreement
with an independent sample38 (Supplementary Figure 29).
Discussion
The pneumococcal population was significantly disrupted by PCV7, with the almost
complete loss of the seven vaccine serotypes and their rapid replacement with non-VT
strains. Whole genome sequencing provides a more detailed view of this process, both
revealing distant relationships between VT and non-VT pneumococci that are difficult to
establish using MLST in many cases, while also indicating ‘capsule switching’ events
between closely related taxa are likely to be old relative to PCV7’s introduction. Hence,
aside from the rise of lineages such as SC3 and SC7, examples of novel genotypes distantly
related to previously observed isolates, the population dynamics are largely the consequence
of VT isolates being replaced by non-VT relatives present at a low frequency before the
vaccine. The clearest example is SC9, where the serotype 23F isolates predominate pre-
PCV7 and are replaced post-vaccination by 23A and 23B isolates. Nevertheless, the
sequence cluster does not fall in prevalence, suggesting its average fitness has not declined,
especially in the context of stable pneumococcal carriage rates. As it seems unlikely the pre-
PCV7 distribution resulted from drift, the data indicate this sequence cluster may occupy a
specific niche that was vacated by 23F post-PCV7. This might be defined by cross-
immunity against serogroup 23 acting as the major constraint on the prevalence of strains
within this group, or by the functional implications of other components of the accessory
genome. Relating the such considerations to the pneumococcus’ population structure will be
important for understanding the impact of partial coverage vaccines.
Replacement of VT strains with non-VT relatives partially explains the stable prevalence of
most accessory loci. Comparison of the pooled data from 2001 and 2007 indicates a
detectable vaccine effect on only a few genes associated with one of the vaccine serotypes
(Figure 4), demonstrating the importance of assigning genomic data to specific taxa rather
than using pooled shotgun reads for studying strain dynamics. That both populations are
composed of distinct strains, themselves representing different combinations of similar loci,
while the IPD rate falls indicates subtle differences within COGs, or consequences of
interactions between them, are crucial in determining the rate at which pneumococci cause
disease within a carrier. As the detectable alterations generally concern the cps locus,
changes in serotype are implicated as the most important factor underlying the decline in
IPD in Massachusetts.
The details of bacterial population restructuring following the introduction of PCV7 may
well differ in locations where the initial bacterial populations, or host characteristics, are
dissimilar from those in this study. Nor are the observed dynamics necessarily representative
of the response over all timescales. While levels of resistance to some antibiotics appear to
have been stable in the samples of this study, based on the surveillance of IPD isolates from
young children across the USA it seems levels of resistance fell immediately after PCV7’s
introduction before rebounding by 200439. This delayed response may be a consequence of
how quickly non-VT resistant pneumococcal lineages could rise in prevalence or, based on
the geographic structuring observed in this study, the speed at which they could spread from
sources where they were present pre-PCV7. Whether the 2007 sample represents a final
equilibrium is unclear. There is little evidence of beneficial post-PCV7 transformation
events in this sample, which may partially relate to the slow rate at which recombinations
are observed to accumulate in lineages. Therefore it seems likely that the bacterial
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tpopulation’s response to vaccine introduction will continue through adaptation to the post-
PCV7 environment via horizontal sequence exchange. On this point, it may be instructive to
note that SC15, associated with the highest r/m, recently appears to have been successful
through rapidly adapting to the post-PCV7 environment13. Hence, while the serotype
distribution may have reached equilibrium by 200717, the response of the pneumococcal
population to the conjugate vaccines is likely to continue.
Methods
DNA sequencing
Samples were sequenced as multiplexed libraries on the Illumina HiSeq platform to produce
paired end reads either 75 nt (for samples from 2001 or 2004) or 100 nt (for samples from
2007) in length. Samples were only used where more than 60 Mb of data (equating to
approximately thirty fold coverage of a pneumococcal genome) were available. Serotypes
and sequence types were extracted as described previously23 and compared to those
recorded in earlier studies to check the integrity of sample handling.
Genome assembly and annotation
Genomes were assembled de novo using Velvet40 through optimizing the kmer and expected
coverage values as described previously23. Short contigs less than twice the length of the
kmer value used in the final assembly were discarded. Both Glimmer341 and Prodigal42
were trained on the complete reference sequence of S. pneumoniae ATCC 70066943, and
these models applied to each draft assembly, modified through the addition of a three frame
stop codon sequence to each end of the genome. A consensus of these two methods was then
derived through only using putative protein coding sequences (CDSs) where the central
halves of the Glimmer3 and Prodigal gene models overlapped on the same strand of the
assembly. Finally, CDSs were trimmed wherever they overlapped breaks in the assembly,
such that they did not span multiple contigs.
Clustering and analysis of orthologous proteins
All putative CDSs were translated and an all-against-all comparison performed using
BLAT44 with default settings. An initial clustering based on these alignments was then
produced using COGtriangles45. COGnitor46 was then used to extract a unique best hit
cluster for each CDS. As COGtriangles requires the presence of at least three orthologues in
the dataset to produce a cluster of orthologues (COG), this left simple sequences, singletons
and pairs of orthologues unclustered. To resolve this, a BLAT E value threshold
corresponding to a p value of 0.05 Bonferroni corrected for the number of reported BLAT
comparisons was established. Unclustered proteins with reciprocal best BLAT hits
surpassing this threshold were paired into COGs with two members. Remaining proteins
were either deemed insufficiently complex to cluster, if their self-BLAT E value was greater
than the threshold, or assigned as singleton COGs.
Each COG was characterized through alignment of the protein sequences with MUSCLE47,
followed by backtranslation into a codon alignment using the DNA sequences. Based on this
alignment, diversity was quantified as the mean pairwise Kimura distance between
members. The codon alignments of the COGs associated with beta lactam and sulfa drug
resistance were analyzed using nextgenBRAT48 with a window size of 100 bp. Recombinant
segments were identified using a p value of 0.05, as calculated through 100 replicates of ten
iterations. Where minimum inhibitory concentrations were specified as ‘less than’ a given
value, the value was halved for the purposes of associating alleles with different levels of
resistance; correspondingly, where ‘greater than’ a specified value was used, the value was
doubled.
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tAnalysis of population structure
The codon alignments of each ‘core’ COG (i.e. those with a single representative in each
genome assembly) were concatenated to give a single ‘core’ alignment. A maximum
likelihood phylogeny was then produced with RAxML49 using a general time reversible
model with four gamma categories for rate heterogeneity. This alignment was also analysed
using BAPS50. Three runs, starting from a maximum cluster number of 20, 40 or 60, each
converged on the 15 monophyletic sequence clusters described, with the exception that one
run added serotype 3 strains to SC7.
Analysis of individual lineages
Fifteen BAPS clusters were monophyletic within the maximum likelihood tree, and
therefore appeared to constitute groups of isolates where not all phylogenetic information
had been abrogated by recombination (i.e. a ‘clonal frame’ remained). One isolate within
each of these groups was selected for reassembly with both SGA51 and Velvet40; these
contigs were merged using Zorro52, then arranged into scaffolds using SSPACE53. These
reference assemblies were then manually curated using ACT54. Illumina read pairs from all
members of the clade were then mapped against this reference using SMALT (http://
www.sanger.ac.uk/resources/software/smalt/), the output of which was processed as
described previously55,56 to produce a whole genome alignment. This was analysed using an
algorithm that iteratively generates a maximum likelihood phylogeny based on point
mutations while identifying recombination events23. When comparing r/m values for
sequence clusters, and comparing the level of recombination observed in each one, branches
on which a total of 5,000 substitutions or more occurred were excluded from the dataset, as
the accuracy of recombination detection was liable to drop on these branches. The difference
in r/m values was still significant, as calculcated by a Kruskal-Walis test, when all branches
were included, as well as at all length cutoff values between 1,000 and 10,000 SNPs at 500
SNP intervals. Recombinations occurring in regions annotated as MGEs in Supplementary
Figure 5–Supplementary Figure 19 were also excluded, as these may represent the transfer
of autonomously mobile elements rather than homologous recombinations. Exponential
distributions were fitted to the lengths of homologous recombinations as described
previously56.
Identification of spatiotemporal signals
Path-O-Gen (http://tree.bio.ed.ac.uk/software/pathogen) was used to examine these lineage
phylogenies for signs of a temporal signal. Where there was a significant positive correlation
between the dates of isolation and root-to-tip distance, the alignment of polymorphisms
caused by point mutations was analysed using BEAST57. The tree topology was fixed, to
maintain consistency with the prediction of recombinations, while a general time reversible
substitution model was allowed to occur with a relaxed lognormal mutation rate58. A skyline
plot was used as the population size prior59.
When analyzing the geographical distribution of isolates, pairwise distances were extracted
from the phylogenies displayed in Supplementary Figure 5–Supplementary Figure 19 using
Bioperl60. When plotted as displayed in Figure 7, an exponential relationship was fitted of
the form:
Where y represents the proportion of strain pairs originating from the same location and x is
the threshold maximum genetic distance, in terms of point mutations, between a pair. C
represents the probability of two strains originating from the same location by chance
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t(estimated as 0.083, 95% confidence interval 0.083–0.084). The sum of A and C represents
the probability that two identical strains come from the same location; A was estimated as
0.86 (95% confidence interval 0.86–0.87). B is the rate at which pairs become discordant for
location per point mutation; this was estimated as 0.038 per mutation (95% confidence
interval 0.038–0.039 per mutation).
Logistic regressions
Logistic regressions were performed using R61. When identifying COGs associated with
different ages, the binary-encoded presence/absence pattern for each COG was regressed
against the age of the host child, in months, and the year of isolation, as categories. These
latter confounding variables were included to guard against different structures to the age
population of sampled children in different years. Children under six months of age were
excluded from the analysis to avoid the confounding effects of maternal immunity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structure of the pneumococcal population. The maximum likelihood phylogeny was
generated using 106,196 polymorphic sites within a 1.14 Mb codon alignment of 1,194
‘core’ COGs. The coloring of this phylogeny represents the sequence clusters (SCs) defined
using the same alignment: fifteen monophyletic sequence clusters are labeled, with the
terminal branches of the tree colored black indicating taxa that constitute a sixteenth
polyphyletic group. Within the monophyletic sequence clusters, light background shading
indicates one particular serotype, with darker shading and dashed lines used to indicate
groups of isolates of alternative serotypes.
Croucher et al. Page 14
Nat Genet. Author manuscript; available in PMC 2013 December 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 2.
Dynamics of the carried pneumococcal population. The proportion of the population
constituted by each of the sequence clusters in the three collection periods is plotted as
adjacent bars. Each bar is split according to the serotype composition of the sequence cluster
in each year; VT capsule types are represented by solid fill, VRT are represented by solid fill
(of the color of the VT of the same serogroup) overlaid with black hatching and non-VT are
represented by colored hatched patterns on a white background. Underneath the chart, the
per site r/m statistic for the fifteen monophyletic clades is displayed, as calculated from the
analyses displayed in Supplementary Figure 5–Supplementary Figure 19.
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Serotype dynamics of SC9. (a) Maximum likelihood phylogeny of SC9 based on point
mutations, excluding polymorphisms introduced through the horizontal import of sequence.
Taxa are labeled with their serotype: all have a serogroup 23 capsule, with the exception of a
single serotype 18C isolate. The taxa are colored according to their year of isolation: red
taxa are from 2001, orange taxa were isolated in 2004, and blue indicates isolates from
2007. Two taxa that developed high-level beta lactam resistance are marked with stars. The
right side of the figure shows the putative recombination events detected acrss the genome
alignment. (b) A simplified annotation of the SC9 reference genome. (c) A heatmap showing
the density of recombination events across the genome, with blue indicating regions
undergoing few, or no, recombinations, while red indicates loci undergoing high rates of
recombination. The highest levels are observed at a putative mobile genetic element (MGE),
in the regions encoding the protein antigens PspA and PspC, and at the capsule biosynthesis
cluster (cps). (d) This panel displays the position of the putative recombination events
relative to the genome annotation, with a row for each taxon in the tree. Each detected
recombination event is indicated by a red block, if reconstructed as occurring on an internal
branch and therefore shared by multiple taxa through common descent, or blue block, if
occurring on a terminal branch and therefore unique to a single taxon.
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Alteration in COG frequency between 2001 and 2007. The logarithm of the odds ratio
indicating the proportion of isolates carrying each COG in 2007 relative to 2001 is displayed
relative to the prevalence of the COG in 2001. Points are colored according to the mean
length of the member proteins, ranging from red (for longer sequences) to blue (for shorter
sequences). The four contours of green shading indicate the positions of the critical values
for significance at confidence intervals of 99.999%, 99.99%, 99.9% and 99% with
increasing intensity. The two labelled points lying outside all these confidence intervals are
involved in synthesis of the serogroup 6 capsules; the other, blue, point is a false positive
that appears to have been introduced through differences in the assembly of data from 2001
(75 nt reads) and 2007 (100 nt reads).
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Distribution of antibiotic resistance genes. The maximum likelihood phylogeny, annotated
as displayed in Figure 1, is emboldened where resistance genes are present and lightly
shaded where they are absent. Taxa containing the resistance genes are linked to a colored
point at the edge of the tree by a radiating line that is red for isolates from 2001, orange for
isolates from 2004, and blue for isolates from 2007. In addition to the sequence clusters, the
multidrug-resistant PMEN1 and PMEN15 lineages are labeled. (a) shows the distribution of
the tetM tetracycline resistance gene. (b) shows the distribution of the ermB macrolide
resistance gene. (c) shows the distribution of the mef gene.
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Changes in beta lactam resistance. (a) Resistance to benzylpenicillin. Each of the three
penicillin binding protein genes involved in resistance was independently clustered on the
basis of sequence similarity using nextgenBRAT; this identified three alleles for pbp1a and
pbp2x and four alleles for pbp2b. Box and whisker plots display the distribution of
benzylpenicillin MICs associated with strains possessing each of these alleles. (b) Box and
whisker plot equivalent to panel (a), but showing MICs to the cephalosporin cefotaxime. (c)
Distribution of pbp alleles throughout the pneumococcal population. The phylogeny
displayed in Figure 1 is shown on the left, with the multidrug-resistant lineages PMEN1
(***), PMEN3 (**) and PMEN15 (*) labeled with asterisks. The three columns on the right
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trepresent the independent analyses for the three pbp genes involved in beta lactam
resistance. These are comprised of one row for each taxon in the tree, with the width of the
column representing the length of the gene. Blocks are colored according to the group to
which the sequence belongs, as indicated by the key at the top of the column; changes of
color indicate recombination breakpoints characteristic of mosaic genes. The ‘O’ group
represents sequence that comes from an ‘outgroup’; that is, from a strain or species not
represented within the collection.
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Geographic structure within the population. The pairwise genetic distance, equating to a
separation in terms of point mutations, between all strains within the same monophyletic
sequence cluster were calculated and combined into a single dataset. For a series of
maximum genetic distance thresholds, the proportion of all pairwise comparisons meeting
the condition that both isolates originated within the same location was calculated. These are
plotted as the black points, which appear to fit an approximately exponential decay,
indicated by the blue line. The red points represent the outcome of one hundred
permutations whereby the same statistic was calculated when the locations of the isolates
were randomized.
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Effect of host age on pneumococcal genotype. A logistic regression coefficient of each COG
against the host child’s age, in months, was calculated. Terms relating to year of isolation
were included in the regression to account for differences in age distributions between
samples, and children under six months of age were excluded to avoid the confounding
effects of maternal immunity. The coefficient relating to host age is plotted against the
prevalence of the COG within the bacterial population; only those present in between 10%
and 90% of the population, suggesting they may be under balancing selection, are displayed.
Points are colored according to the mean length of the member proteins, ranging from red
(for longer sequences) to blue (for shorter sequences).
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